Jiankang Zhang was graduated from Tongji University. During his PhD period, he was focused on the breast cancer lung metastasis. He found that LRP6 ectodomain was shed and released in the serum, which was related with cancer metastasis progress and could inhibit breast cancer metastasis through interacting with CXCR4. He joined in our lab in 2021 and is now working on prostate cancer bone metastasis using CRISPR-Cas9 screening.